FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2284619935> ?p ?o ?g. }

• W2284619935 endingPage "73" @default.
• W2284619935 startingPage "61" @default.
• W2284619935 abstract "Patients with type II diabetes have an increased risk of bladder cancer and are commonly treated with thiazolidinediones and angiotensin receptor blockers (ARBs), which have been linked to cancer risk. We explored the relationship between use of one or both of these medication types and incident bladder cancer among diabetic patients (diabetics) enrolled in Medicare. We constructed both a prevalent and incident retrospective cohort of pharmacologically treated prevalent diabetics enrolled in a Medicare fee-for-service plan using inpatient, outpatient (2003–2011) and prescription (2006–2011) administrative data. The association of incident bladder cancer with exposure to pioglitazone, rosiglitazone and ARBs was studied using muitivariable Cox’s hazard models with time-dependent covariates in each of the two cohorts. We identified 1,161,443 prevalent and 320,090 incident pharmacologically treated diabetics, among whom 4433 and 1159, respectively, developed incident bladder cancers. In the prevalent cohort mean age was 75.1 years, mean follow-up time was 38.0 months, 20.2% filled a prescription for pioglitazone during follow-up, 10.4% received rosiglitazone, 31.6% received an ARB and 8.0% received combined therapy with pioglitazone + ARB. We found a positive association between bladder cancer and duration of pioglitazone use in the prevalent cohort (P for trend = 0.008), with ≥24 months of pioglitazone exposure corresponding to a 16% (95% confidence interval 0–35%) increase in the incidence of bladder cancer compared to no use. There was a positive association between bladder cancer and rosiglitazone use for <24 months in the prevalent cohort, but no association with ARB use. There were no significant associations in the incident cohort. We found that the incidence of bladder cancer increased with duration of pioglitazone use in a prevalent cohort of diabetics aged 65+ years residing in the USA, but not an incident cohort." @default.
• W2284619935 created "2016-06-24" @default.
• W2284619935 creator A5005224177 @default.
• W2284619935 creator A5028691600 @default.
• W2284619935 creator A5062649421 @default.
• W2284619935 creator A5068379220 @default.
• W2284619935 creator A5086325206 @default.
• W2284619935 date "2016-02-19" @default.
• W2284619935 modified "2023-10-10" @default.
• W2284619935 title "Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study" @default.
• W2284619935 cites W108690756 @default.
• W2284619935 cites W1752522506 @default.
• W2284619935 cites W1920604003 @default.
• W2284619935 cites W1937645242 @default.
• W2284619935 cites W1976655891 @default.
• W2284619935 cites W1977156691 @default.
• W2284619935 cites W1990586051 @default.
• W2284619935 cites W1997303839 @default.
• W2284619935 cites W2000445173 @default.
• W2284619935 cites W2001498457 @default.
• W2284619935 cites W2006212865 @default.
• W2284619935 cites W2007307191 @default.
• W2284619935 cites W2012167887 @default.
• W2284619935 cites W2018137366 @default.
• W2284619935 cites W2029525421 @default.
• W2284619935 cites W2029655516 @default.
• W2284619935 cites W2030404218 @default.
• W2284619935 cites W2036222770 @default.
• W2284619935 cites W2041573811 @default.
• W2284619935 cites W2043984491 @default.
• W2284619935 cites W2048013457 @default.
• W2284619935 cites W2066223906 @default.
• W2284619935 cites W2068753267 @default.
• W2284619935 cites W2069723602 @default.
• W2284619935 cites W2081540191 @default.
• W2284619935 cites W2092389956 @default.
• W2284619935 cites W2099929207 @default.
• W2284619935 cites W2104195235 @default.
• W2284619935 cites W2105473163 @default.
• W2284619935 cites W2115060720 @default.
• W2284619935 cites W2119184048 @default.
• W2284619935 cites W2120386078 @default.
• W2284619935 cites W2128584370 @default.
• W2284619935 cites W2132054370 @default.
• W2284619935 cites W2138121862 @default.
• W2284619935 cites W2148755064 @default.
• W2284619935 cites W2149569244 @default.
• W2284619935 cites W2150542303 @default.
• W2284619935 cites W2151190595 @default.
• W2284619935 cites W2163531555 @default.
• W2284619935 cites W2163886829 @default.
• W2284619935 doi "https://doi.org/10.1007/s13300-016-0152-4" @default.
• W2284619935 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4801809" @default.
• W2284619935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26894755" @default.
• W2284619935 hasPublicationYear "2016" @default.
• W2284619935 type Work @default.
• W2284619935 sameAs 2284619935 @default.
• W2284619935 citedByCount "15" @default.
• W2284619935 countsByYear W22846199352017 @default.
• W2284619935 countsByYear W22846199352018 @default.
• W2284619935 countsByYear W22846199352019 @default.
• W2284619935 countsByYear W22846199352020 @default.
• W2284619935 countsByYear W22846199352021 @default.
• W2284619935 countsByYear W22846199352022 @default.
• W2284619935 crossrefType "journal-article" @default.
• W2284619935 hasAuthorship W2284619935A5005224177 @default.
• W2284619935 hasAuthorship W2284619935A5028691600 @default.
• W2284619935 hasAuthorship W2284619935A5062649421 @default.
• W2284619935 hasAuthorship W2284619935A5068379220 @default.
• W2284619935 hasAuthorship W2284619935A5086325206 @default.
• W2284619935 hasBestOaLocation W22846199351 @default.
• W2284619935 hasConcept C120665830 @default.
• W2284619935 hasConcept C121332964 @default.
• W2284619935 hasConcept C121608353 @default.
• W2284619935 hasConcept C126322002 @default.
• W2284619935 hasConcept C134018914 @default.
• W2284619935 hasConcept C143998085 @default.
• W2284619935 hasConcept C167135981 @default.
• W2284619935 hasConcept C207103383 @default.
• W2284619935 hasConcept C2776923340 @default.
• W2284619935 hasConcept C2777180221 @default.
• W2284619935 hasConcept C2778384471 @default.
• W2284619935 hasConcept C2779306644 @default.
• W2284619935 hasConcept C2780152017 @default.
• W2284619935 hasConcept C2780352672 @default.
• W2284619935 hasConcept C44249647 @default.
• W2284619935 hasConcept C50382708 @default.
• W2284619935 hasConcept C555293320 @default.
• W2284619935 hasConcept C61511704 @default.
• W2284619935 hasConcept C71924100 @default.
• W2284619935 hasConcept C72563966 @default.
• W2284619935 hasConceptScore W2284619935C120665830 @default.
• W2284619935 hasConceptScore W2284619935C121332964 @default.
• W2284619935 hasConceptScore W2284619935C121608353 @default.
• W2284619935 hasConceptScore W2284619935C126322002 @default.
• W2284619935 hasConceptScore W2284619935C134018914 @default.
• W2284619935 hasConceptScore W2284619935C143998085 @default.
• W2284619935 hasConceptScore W2284619935C167135981 @default.

• next